Below is a breakdown of the 10 top-selling drugs globally:
1. Humira (AbbVie) $19.9 billion
2. Revlimid (Celgene) $9.7 billion
3. Keytruda (Merck & Co.) $7.2 billion
4. Herceptin (Roche) $7.1 billion
5. Avastin (Roche) $7.0 billion
6. Rituxan (Roche) $6.9 billion
7. Opdivo (Bristol-Myers Squibb) $6.7 billion
8. Eliquis (Bristol-Myers Squibb) $6.4 billion
9. Prevnar 13 (Pfizer) $5.8 billion
10. Stelara (Johnson & Johnson) $5.2 billion
More articles on pharmacy:
Bristol-Myers urges shareholders to support Celgene takeover
Novartis to pay $23M to settle claims it used charity payments as kickbacks
Martin Shkreli reportedly running his pharma company from prison
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
